January 22, 2018 / 12:18 PM / 3 months ago

BRIEF-European Commission Approves Bristol-Myers Squibb's Yervoy

Jan 22 (Reuters) - Bristol-Myers Squibb Co:

* EUROPEAN COMMISSION APPROVES BRISTOL-MYERS SQUIBB’S YERVOY (IPILIMUMAB) FOR TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH UNRESECTABLE OR METASTATIC MELANOMA

* BRISTOL-MYERS SAYS EC EXPANDED INDICATION OF YERVOY TO INCLUDE TREATMENT OF ADVANCED MELANOMA IN PEDIATRIC PATIENTS 12 YRS OF AGE & OLDER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below